Sign In

Communications of the ACM

ACM News

­se of Personalized Cancer Drugs Runs Ahead of the Science

View as: Print Mobile App Share:
Personalized cancer drugs

More than 30% of cancer drugs are prescribed to treat conditions for which they have not been specifically approved.

Credit: Hero Images/Getty

As the costs of genetic sequencing fall, oncologists are starting to prescribe expensive new drugs that target the genetic profiles of their patients' tumours, even when those treatments have not been approved for the particular cancer involved.

From Nature
View Full Article



No entries found